Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GDA | Q9Y2T3 | 2/20 | 0.94 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | TYMP | P19971 | 5/20 | 0.39 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | IDH1 | O75874 | 1/20 | 0.39 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Uric Acid SCHEMBL3417988 | 0.97 | GDA (1.00) | GDAALDH1A1CYP1A2CYP2C9HPGD | |
| Uric Acid SCHEMBL30062557 | 0.97 | GDA (1.00) | GDAALDH1A1CYP1A2CYP2C9HPGD | |
| Uric Acid SCHEMBL7933 | 0.97 | GDA (1.00) | GDAALDH1A1CYP1A2CYP2C9HPGD | |
| Uric Acid SCHEMBL1071965 | 0.94 | GDA (0.94) | GDAALDH1A1CYP1A2CYP2C9HPGD | |
| Uric Acid SCHEMBL925499 | 0.94 | GDA (0.94) | GDAALDH1A1CYP1A2CYP2C9HPGD | |
| Uric Acid SCHEMBL11423974 | 0.94 | GDA (0.94) | GDAALDH1A1CYP1A2CYP2C9HPGD | |
| Uric Acid SCHEMBL196769 | 0.94 | GDA (0.94) | GDAALDH1A1CYP1A2CYP2C9HPGD | |
| Uric Acid SCHEMBL2434620 | 0.94 | GDA (0.94) | GDAALDH1A1CYP1A2CYP2C9HPGD | |
| Uric Acid SCHEMBL229866 | 0.94 | GDA (0.94) | GDAALDH1A1CYP1A2CYP2C9HPGD | |
| Uric Acid SCHEMBL10631703 | 0.94 | GDA (0.94) | GDAALDH1A1CYP1A2CYP2C9HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110343321-A | A kind of PVC calcium-zinc composite stabilizing agent and its technological process of production | 宿州市杰牌化学有限公司 | 2019-10-18 | — | — | CN | claimed |
| CN-110204712-A | A kind of method of synthesis in solid state cyanuric acid-uracil complexing zinc salt | 深圳市志海实业股份有限公司 | 2019-09-06 | — | — | CN | claimed |
| EP-1843822-A1 | AN EMULSION COMPOSITION FOR WET WIPES CONTAINING A NON-IRRITATING SKIN HEALTH BENEFIT INGREDIENT AND THE PROCESS FOR MAKING SAID WET-WIPES | The Procter and Gamble Company (US) | 2007-10-17 | — | — | EP | claimed |
| WO-2006083980-A1 | AN EMULSION COMPOSITION FOR WET WIPES CONTAINING A NON-IRRITATING SKIN HEALTH BENEFIT INGREDIENT AND THE PROCESS FOR MAKING SAID WET-WIPES | THE PROCTER & GAMBLE COMPANY (US) | 2006-08-10 | — | — | WO | claimed |
| US-20060171971-A1 | Composition for wet wipes containing a non-irritating skin health benefit ingredient and the process for making | THE PROCTER & GAMBLE COMPANY | 2006-08-03 | — | — | US | claimed |
| CN-114402043-B | Dispersion and coating composition comprising inorganic oxide particles and zinc cyanurate particles | 日产化学株式会社 | 2023-06-30 | — | — | CN | disclosed |
| CN-116144213-A | Dispersion comprising inorganic oxide particles and zinc cyanurate particles | 日产化学株式会社 | 2023-05-23 | — | — | CN | disclosed |
| EP-2666458-B1 | PRE-MIX FOR A NON-LATHERING PERSONAL CARE ARTICLE, THE ARTICLE HAVING THE FORM OF A SOLID FOAM | PROCTER & GAMBLE (US) | 2021-09-29 | — | — | EP | disclosed |
| EP-2666457-B1 | Process for forming a non-lathering personal care article in the form of a dissolvable solid foam | PROCTER & GAMBLE (US) | 2020-06-17 | — | — | EP | disclosed |
| CN-110343321-A | A kind of PVC calcium-zinc composite stabilizing agent and its technological process of production | 宿州市杰牌化学有限公司 | 2019-10-18 | — | — | CN | disclosed |
| CN-110343321-A | A kind of PVC calcium-zinc composite stabilizing agent and its technological process of production | 宿州市杰牌化学有限公司 | 2019-10-18 | — | — | CN | disclosed |
| CN-106660973-B | The manufacturing method of alkali formula cyanuric acid zinc powder and the manufacturing method of rustproof pigment composition | 日产化学工业株式会社 | 2019-04-23 | — | — | CN | disclosed |
| EP-1496887-A1 | PERSONAL CARE COMPOSITIONS COMPRISING A ZINC CONTAINING MATERIAL IN AN AQUEOUS SURFACTANT COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2005-01-19 | — | — | EP | disclosed |
| EP-1496899-A1 | USE OF MATERIALS HAVING ZINC IONOPHORIC BEHAVIOR | THE PROCTER & GAMBLE COMPANY (US) | 2005-01-19 | — | — | EP | disclosed |
| US-20040191331-A1 | Composition comprising particulate zinc materials having a defined crystallite size | THE PROCTER & GAMBLE COMPANY | 2004-09-30 | — | — | US | disclosed |
| WO-2004082648-A1 | COMPOSITION COMPRISING PARTICULATE ZINC MATERIALS HAVING A DEFINED CRYSTALLITE SIZE | THE PROCTER & GAMBLE COMPANY (US) | 2004-09-30 | — | — | WO | disclosed |
| US-20040058855-A1 | Use of materials having zinc ionophoric behavior | THE PROCTOR & GAMBLE COMPANY | 2004-03-25 | — | — | US | disclosed |
| US-20030215522-A1 | Personal care compositions comprising a zinc containing material in an aqueous surfactant composition | THE PROCTER & GAMBLE COMPANY | 2003-11-20 | — | — | US | disclosed |
| WO-2003088965-A1 | USE OF MATERIALS HAVING ZINC IONOPHORIC BEHAVIOR | THE PROCTER & GAMBLE COMPANY (US) | 2003-10-30 | — | — | WO | disclosed |
| WO-2003088957-A1 | PERSONAL CARE COMPOSITIONS COMPRISING A ZINC CONTAINING MATERIAL IN AN AQUEOUS SURFACTANT COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2003-10-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040058855-A1 | Use of materials having zinc ionophoric behavior | SLC30A6, SLC39A7, SLC30A7 | GDA 1108/4885ALDH1A1 3065/4885CYP1A2 1597/4885 |
| US-20040191331-A1 | Composition comprising particulate zinc materials having a defined crystallite size | PPOX, LPO, THOC2 | GDA 4680/4885ALDH1A1 4521/4885CYP1A2 2954/4885 |
| US-20030215522-A1 | Personal care compositions comprising a zinc containing material in an aqueous surfactant composition | SLC30A7, SLC39A7, SOD1 | GDA 4065/4885ALDH1A1 4256/4885CYP1A2 4813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.